Versant Capital Management, Inc Natera, Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 236 shares of NTRA stock, worth $33,969. This represents 0.01% of its overall portfolio holdings.
Number of Shares
236
Previous 214
10.28%
Holding current value
$33,969
Previous $33,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding NTRA
# of Institutions
638Shares Held
120MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.77 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$975 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$971 Million0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$965 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$638 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $14B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...